Living with dry age-related macular degeneration (Dry AMD) can be frustrating, especially when changes in vision begin to affect daily activities like reading, recognizing faces, or seeing clearly in low-light environments. At Acton Eyecare, we are committed to offering patients thoughtful, evidence-informed care and access to emerging treatment options that may help support visual function.
What is MacuMira?
MacuMira is a non-invasive, Health Canada–approved medical device designed to help improve visual function in patients with Dry AMD. MacuMira delivers a gentle microcurrent through closed eyelids during in-clinic treatment sessions. This microcurrent is intended to support the health and function of retinal cells, including cellular and mitochondrial activity, which are affected in Dry AMD. MacuMira is designed to be used alongside existing Dry AMD management, not as a replacement for regular monitoring or supplements.Who Could Benefit From MacuMira Treatment?
MacuMira may be appropriate for individuals with Dry AMD at various stages, particularly those who are looking for additional options to support visual function. The best way to determine whether MacuMira may be suitable is through a consultation with our clinical team.What to Expect During Your MacuMira Treatment
MacuMira treatments are performed comfortably in our clinic. During each session:- You will sit in a relaxing treatment chair
- The MacuMira device is placed gently over closed eyelids
- Treatment lasts 32 minutes
- No injections, surgery, or downtime are required
Benefits of MacuMira Treatment for Dry AMD
While individual results vary, patients using MacuMira have reported benefits such as:- Improved visual function for daily activities
- Better contrast sensitivity, especially in low-light situations
- Increased confidence with tasks affected by central vision changes